Recombinant Human HSPC171 Protein，GST

HSPC171, also known as non-specific cytotoxic cell receptor protein 1 (NCR1), is a member of the C-type lectin-like receptor family and has garnered attention in immunology research due to its role in immune responses, particularly in natural killer (NK) cells and certain T-cell populations. Understanding the molecular mechanisms of HSPC171 is crucial, as it is implicated in various physiological and pathological processes, including tumor immunology and autoimmune diseases. The focus on recombinant HSPC171 protein stems from its potential applications in therapeutic strategies, such as cancer immunotherapy, where enhancing NK cell activity can improve tumor targeting and elimination. Research has demonstrated that HSPC171 can modulate immune signaling pathways, making it a viable candidate for further investigations into its structural properties and functional dynamics. By generating recombinant HSPC171, scientists aim to explore its binding characteristics, evaluate its immunogenicity, and assess its effects on various immune cell types. This research is essential not only for understanding the basic biology of HSPC171 but also for its potential utilization in developing innovative immunotherapeutic approaches to treat cancers and other immune-related disorders. Thus, advances in the study of HSPC171 and its recombinant protein provide a critical foundation for future breakthroughs in immunology and therapeutic interventions.